Search Videos by Topic or Participant
Browse by Series:

Final Thoughts on Improving Outcomes in CRC

Panelists: Axel F. Grothey, MD , Mayo Clinic ; Daniel G. Haller, MD, University of Pennsylvania; Herbert I. Hurwitz, MD, Duke University Medical Center; J
Published: Sunday, Jun 07, 2015


In the final segment of the discussion, the expert panel shares their thoughts on the current state of treatment for patients with metastatic colorectal cancer (mCRC).

Dan Haller, MD, explains that overall survival for mCRC has improved 5-fold since he trained as a fellow, back when there was only fluorouracil; in fact, some patients with metastatic disease are now being cured. It’s important to realize how far we’ve come, he comments.

Axel Grothey, MD, says there is no clear winner when it comes to choosing first-line therapy for mCRC. There are several options, and it’s not a one-size-fits-all scenario. The next generation of big questions will be answered by diving into the subset analyses of large phase III studies, he suggests.
Slider Left
Slider Right


In the final segment of the discussion, the expert panel shares their thoughts on the current state of treatment for patients with metastatic colorectal cancer (mCRC).

Dan Haller, MD, explains that overall survival for mCRC has improved 5-fold since he trained as a fellow, back when there was only fluorouracil; in fact, some patients with metastatic disease are now being cured. It’s important to realize how far we’ve come, he comments.

Axel Grothey, MD, says there is no clear winner when it comes to choosing first-line therapy for mCRC. There are several options, and it’s not a one-size-fits-all scenario. The next generation of big questions will be answered by diving into the subset analyses of large phase III studies, he suggests.
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Cancer Summaries and Commentaries™: Update from Chicago: Advances in the Treatment of Breast CancerJul 31, 20181.0
Community Practice Connections™: The Next Generation in Renal Cell Carcinoma Treatment: An Oncology Nursing Essentials WorkshopJul 31, 20181.5
Publication Bottom Border
Border Publication
x